Metropolitan Life Insurance Company (MetLife)’s Pfenex Inc. PFNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,825
Closed -$98.7K 2610
2020
Q2
$98.7K Buy
11,825
+1,065
+10% +$7.97K ﹤0.01% 2260
2020
Q1
$94.9K Buy
10,760
+709
+7% +$7.79K ﹤0.01% 2057
2019
Q4
$110K Sell
10,051
-1,161
-10% -$11.5K ﹤0.01% 2275
2019
Q3
$94.6K Buy
+11,212
New +$81.3K ﹤0.01% 2331
2016
Q1
Sell
-12,344
Closed -$153K 2544
2015
Q4
$153K Hold
12,344
﹤0.01% 2423
2015
Q3
$185K Hold
12,344
﹤0.01% 2340
2015
Q2
$239K Buy
+12,344
New +$207K ﹤0.01% 2281

Other funds holding PFNX

Metropolitan Life Insurance Company (MetLife)'s PFNX Position: Q3 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Pfenex Inc. (PFNX) in Q3 2020, closing a stake of 11,825 shares — an estimated $98.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PFNX in Q2 2015 and held it in 7 quarters. The position peaked at $239K in Q2 2015. 55 funds tracked by Wall St. Rank hold PFNX as of Q3 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Pfenex Inc. position as of Q3 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 11,825 Pfenex Inc. shares in Q3 2020, an estimated $98.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Pfenex Inc. in Q2 2015 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Pfenex Inc. position peaked at $239K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Pfenex Inc. as of Q3 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2020, filed 13 Nov 2020.